MDM2 Gene Complete Identifier and Functional Mapping Reference

Provide a comprehensive cross-database identifier and functional mapping reference for human MDM2. This should serve as a definitive lookup resource …

Provide a comprehensive cross-database identifier and functional mapping reference for human MDM2. This should serve as a definitive lookup resource for researchers. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 1: GENE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Provide ALL gene-level database identifiers: - HGNC ID and approved symbol - Ensembl gene ID (ENSG) - NCBI Entrez Gene ID - OMIM gene/locus ID - Genomic location: chromosome, start position, end position, strand ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 2: TRANSCRIPT IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL transcript-level identifiers: - Ensembl transcripts: ALL ENST IDs with biotype (protein_coding, etc.) How many total transcripts? - RefSeq transcripts: ALL NM_ mRNA accessions Mark which is MANE Select (canonical clinical standard) - CCDS IDs: ALL consensus coding sequence identifiers For the CANONICAL/MANE SELECT transcript: - List ALL exon IDs (ENSE) with genomic coordinates - Total exon count ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 3: PROTEIN IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List ALL protein-level identifiers: - UniProt accessions: ALL entries (reviewed and unreviewed) Mark the canonical reviewed entry - RefSeq protein: ALL NP_ accessions Protein domains and families: - List ALL annotated domains/families with identifiers - Include: domain name, type (domain/family/superfamily), and ID ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 4: STRUCTURE IDENTIFIERS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Experimental structures: - List ALL PDB structure IDs - For each: experimental method (X-ray, NMR, Cryo-EM) and resolution - Total PDB structure count Predicted structures: - AlphaFold model ID and confidence metrics (pLDDT) ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 5: CROSS-SPECIES ORTHOLOGS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ List orthologous genes in key model organisms (where available): - Mouse (Mus musculus): gene ID, symbol - Rat (Rattus norvegicus): gene ID, symbol - Zebrafish (Danio rerio): gene ID, symbol - Fruit fly (Drosophila melanogaster): gene ID, symbol - Worm (C. elegans): gene ID, symbol - Yeast (S. cerevisiae): gene ID, symbol ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 6: CLINICAL VARIANTS & AI PREDICTIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Clinical variant annotations: - Total variant count in clinical databases - Breakdown by classification: Pathogenic, Likely Pathogenic, Uncertain Significance (VUS), Likely Benign, Benign - List TOP 50 pathogenic/likely pathogenic variants with: variant ID, HGVS notation, associated condition AI-based variant effect predictions: - Splice effect predictions: Total count List TOP 50 predicted splice-altering variants with delta scores - Missense pathogenicity predictions: Total count List TOP 50 predicted pathogenic missense variants with scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 7: BIOLOGICAL PATHWAYS & GENE ONTOLOGY ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Pathway membership: - List ALL biological pathways this gene participates in - Include pathway IDs and names - Total pathway count Gene Ontology annotations: - Biological Process: count and TOP 20 terms with IDs - Molecular Function: count and TOP 20 terms with IDs - Cellular Component: count and TOP 20 terms with IDs ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 8: PROTEIN INTERACTIONS & MOLECULAR NETWORKS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Protein-protein interactions: - Total interaction count - List TOP 50 highest-confidence interacting proteins with scores Protein similarity (evolutionary and structural): - Structural/embedding similarity: How many similar proteins? List TOP 20 with similarity scores - Sequence homology: How many homologous proteins? List TOP 20 with identity/similarity scores ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 9: TRANSCRIPTION FACTOR REGULATORY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene encodes a transcription factor: Downstream targets (genes regulated BY this TF): - Total target gene count - List TOP 50 target genes with regulation type (activates/represses) DNA binding profiles: - List ALL known binding motif IDs - Motif family classification Upstream regulators (TFs that regulate THIS gene): - List known transcriptional regulators with evidence type ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 10: DRUG & PHARMACOLOGY DATA ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ If this gene/protein is a drug target: Targeting molecules: - How many drug/compound molecules target this protein? - List TOP 30 molecules by development phase - Include: molecule ID, name, mechanism, highest development phase Clinical trials: - How many clinical trials involve drugs targeting this gene? - List TOP 20 trials with: trial ID, phase, status, intervention Pharmacogenomics: - Known drug-gene interactions affecting drug response - Dosing guidelines if any exist ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 11: EXPRESSION PROFILES ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Tissue expression: - Which tissues express this gene most highly? - List TOP 30 tissues with expression scores/levels - Note any tissue-specific or tissue-enriched patterns Cell type expression: - Which cell types show highest expression? - List TOP 30 cell types with expression scores - Note any cell type-specific patterns Single-cell expression data (if available): - Which single-cell datasets/experiments include this gene? - Notable cell population patterns ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ SECTION 12: DISEASE ASSOCIATIONS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ Mendelian/monogenic disease links: - What diseases are caused by mutations in this gene? - List ALL associated diseases with: disease name, disease ID, inheritance pattern, evidence level Phenotype associations: - What clinical phenotypes are associated with this gene? - List TOP 50 phenotype terms with IDs Complex trait associations (GWAS): - What traits/diseases are linked via genome-wide association studies? - List TOP 30 GWAS associations with: trait, study ID, p-value, effect size if available ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ FORMATTING REQUIREMENTS ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ - Present each section with clear headers - Use tables for listing multiple items - Always include COUNTS for every category - For lists with >50 items: show total count + TOP 50 - For lists with <50 items: show ALL items - Always include database identifiers (IDs), not just names - Mark canonical/primary/reviewed entries where applicable - If a section has no data available, state "No data available" rather than omitting the section

Structured Data Sources

This answer was generated using Claude Opus 4.5 + BioBTree MCP, querying 37 biological databases.

Further analyze this answer or run your own queries with BioBTree MCP.

Datasets: alphafold, alphamissense, bgee, bgee_evidence, biogrid_interaction, ccds, chembl_molecule, chembl_target, clinical_trials, clinvar, collectri, diamond_similarity, ensembl, entrez, esm2_similarity, exon, gencc, go, gwas, hgnc, hpo, interpro, mim, orphanet, ortholog, pdb, pfam, pharmgkb, pharmgkb_gene, reactome, refseq, scxa, signor, spliceai, string_interaction, transcript, uniprot
Generated: 2026-03-29 — For the latest data, query BioBTree directly via MCP or API.
View API calls (51)
MDM2

Section 1: Gene Identifiers

DatabaseIdentifierDescription
HGNCHGNC:6973Approved symbol: MDM2
Ensembl GeneENSG00000135679MDM2 proto-oncogene
NCBI Entrez Gene4193MDM2 proto-oncogene
OMIM164785Gene/locus entry
PharmGKB GenePA30718VIP gene status: true
Genomic Location
AttributeValue
Chromosome12
Cytogenetic Band12q15
Start Position68,808,171
End Position68,850,685
Strand+ (forward)
Genomic AccessionNC_000012.12
Gene Span~42.5 kb
Gene Nomenclature
CategoryNames
Approved NameMDM2 proto-oncogene
Previous NamesMouse double minute 2; Mdm2 p53 binding protein homolog; MDM2 proto-oncogene, E3 ubiquitin protein ligase
AliasesHDM2, MGC5370, ACTFS, HDMX, LSKB, hdm2
Gene GroupsRing finger proteins; Zinc fingers RANBP2-type
Locus TypeProtein-coding gene

Section 2: Transcript Identifiers Ensembl Transcripts Total transcript count: 40

Transcript IDBiotypeStartEndNotes
ENST00000258149protein_coding68,808,17768,845,544Canonical
ENST00000258148protein_coding68,808,46468,839,867
ENST00000299252protein_coding68,809,21268,839,849
ENST00000311420nonsense_mediated_decay68,808,27368,839,867
ENST00000348801protein_coding68,809,22668,839,849
ENST00000350057protein_coding68,809,21268,839,849
ENST00000360430protein_coding68,809,21268,839,849
ENST00000393410protein_coding68,809,21268,839,849
ENST00000393412protein_coding68,808,19168,840,216
ENST00000393413protein_coding68,809,21268,839,849
ENST00000393415protein_coding68,809,01768,839,282
ENST00000393416protein_coding68,809,02468,839,961
ENST00000393417nonsense_mediated_decay68,808,38368,839,856
ENST00000400501protein_coding_CDS_not_defined68,843,68968,844,195
ENST00000471946retained_intron68,813,60268,820,414
ENST00000478070protein_coding68,809,22668,839,849
ENST00000481186nonsense_mediated_decay68,809,21168,839,849
ENST00000493419retained_intron68,808,28268,817,018
ENST00000496959nonsense_mediated_decay68,809,21268,839,849
ENST00000517852protein_coding68,809,21268,839,849
ENST00000523991protein_coding68,809,01768,839,314
ENST00000536089nonsense_mediated_decay68,809,21268,839,849
ENST00000537182nonsense_mediated_decay68,809,21268,839,849
ENST00000539479protein_coding68,809,00268,840,807
ENST00000540352nonsense_mediated_decay68,809,21268,839,849
ENST00000540709protein_coding_CDS_not_defined68,842,44168,844,181
ENST00000542502nonsense_mediated_decay68,809,21268,839,849
ENST00000543046retained_intron68,824,20368,824,758
ENST00000543323protein_coding68,809,01768,839,314
ENST00000544125protein_coding_CDS_not_defined68,843,06668,844,190
ENST00000544561protein_coding68,809,21268,839,961
ENST00000545204protein_coding68,809,21268,839,961
ENST00000546048nonsense_mediated_decay68,809,21268,839,849
ENST00000665020nonsense_mediated_decay68,809,21268,839,961
ENST00000666617nonsense_mediated_decay68,809,21268,839,961
ENST00000671567nonsense_mediated_decay68,809,21268,839,961
ENST00000890006protein_coding68,808,17768,840,490
ENST00000890007protein_coding68,808,20168,840,271
ENST00000951805protein_coding68,808,17568,843,376
ENST00000951806protein_coding68,808,40568,840,540
RefSeq Transcripts (Human) Total: 10 human mRNA transcripts
RefSeq IDStatusMANE SelectChromosome
NM_002392REVIEWED✓ YES12
NM_001145337REVIEWEDNo12
NM_001145339REVIEWEDNo12
NM_001145340REVIEWEDNo12
NM_001278462REVIEWEDNo12
NM_001367990REVIEWEDNo12
RefSeq Proteins (Human)
RefSeq ProteinStatusMANE Select
NP_002383REVIEWED✓ YES
NP_001138809REVIEWEDNo
NP_001138811REVIEWEDNo
NP_001138812REVIEWEDNo
NP_001265391REVIEWEDNo
NP_001354919REVIEWEDNo
CCDS IDs
CCDS ID
CCDS8986
CCDS61189
CCDS91724
Canonical Transcript Exons (ENST00000258149) Total Exon Count: 11
Exon IDStartEndLength (bp)
ENSE0000191965668,808,17768,808,491315
ENSE0000350071968,809,20868,809,29285
ENSE0000346955168,813,55468,813,62875
ENSE0000352791968,816,81268,816,945134
ENSE0000368485268,820,32568,820,37450
ENSE0000368336668,824,36368,824,43068
ENSE0000367492868,824,55568,824,65197
ENSE0000359751168,828,77168,828,931161
ENSE0000364527968,835,82968,835,984156
ENSE0000347600068,836,67268,836,74978
ENSE0000221505268,839,27468,845,5446,271

Section 3: Protein Identifiers UniProt Accessions

UniProt IDStatusProtein NameLengthMass
Q00987Reviewed (Swiss-Prot)E3 ubiquitin-protein ligase Mdm2491 aa55,233 Da
Alternative Names
  • Double minute 2 protein
  • Oncoprotein Mdm2
  • RING-type E3 ubiquitin transferase Mdm2
  • p53-binding protein Mdm2 Protein Domains and Families (InterPro) Total: 9 entries
InterPro IDNameType
IPR001841Znf_RINGDomain
IPR001876Znf_RanBP2Domain
IPR003121SWIB_MDM2_domainDomain
IPR013083Znf_RING/FYVE/PHDHomologous_superfamily
IPR016495p53_neg-reg_MDM_2/4Family
IPR028340Mdm2Family
IPR036443Znf_RanBP2_sfHomologous_superfamily
IPR036885SWIB_MDM2_dom_sfHomologous_superfamily
IPR044080MDM2_mRING-HC-C2H2C4Domain
Pfam Domains
Pfam IDDescription
PF00641RING finger domain
PF02201SWIB/MDM2 domain
PF13920Zinc finger, RanBP2-type

Section 4: Structure Identifiers Experimental Structures (PDB) Total PDB structure count: 147+ Representative Structures (TOP 50)

PDB IDMethodResolution (Å)Description
1YCRX-RAY2.6MDM2 bound to p53 transactivation domain
1T4FX-RAY1.9MDM2 with optimized p53 peptide
1RV1X-RAY2.3MDM2 with imidazoline inhibitor
1T4EX-RAY2.6MDM2 with benzodiazepine inhibitor
1Z1MNMR-Unliganded MDM2 structure
2AXIX-RAY1.4HDM2 with beta-hairpin inhibitor
2C6ANMR-C4 zinc-finger domain of HDM2
2HDPNMR-Hdm2 RING finger domain
2VJEX-RAY2.2MDM2-MDMX RING domain heterodimer
3EQSX-RAY1.65MDM2 with 12-mer peptide inhibitor
3G03X-RAY1.8MDM2 with high affinity peptide
3IUXX-RAY1.65MDM2 with miniature protein inhibitor
4HG7X-RAY1.6MDM2 with Nutlin-3a
4WT2X-RAY1.42MDM2 with AM-7209 inhibitor
5C5AX-RAY1.15HDM2 with Nutlin-3a (high resolution)
5OC8X-RAY1.56HDM2 with NVP-HDM201
5TRFX-RAY2.1MDM2 with SAR405838
5MNJX-RAY2.16MDM2-MDMX-UbcH5B-ubiquitin complex
5ZXFX-RAY1.25His6-tagged Mdm2 with nutlin-3a
6SQOX-RAY1.41MDM2 RING domain homodimer
6GGNX-RAY2.0MDM2 with potent p53-MDM2 inhibitor
6Q9LX-RAY1.13HDM2 with compound 9 (ultrahigh res)
6Q9OX-RAY1.21HDM2 with compound 10
7QDQX-RAY1.26HDM2 with Caylin-1
8PWCX-RAY1.46MDM2 with Brigimadlin
8BGUCRYO-EM4.1Human MDM2-5S RNP complex
8F10X-RAY1.28MDM2 with all-D Helicon Polypeptide
Predicted Structures (AlphaFold)
Model IDGlobal pLDDTSequence LengthFraction Very High Confidence
AF-Q00987-F163.243,8590.30 (30%)

Section 5: Cross-Species Orthologs

SpeciesEnsembl Gene IDGene SymbolGenome
Mouse (Mus musculus)ENSMUSG00000020184Mdm2mus_musculus
Rat (Rattus norvegicus)ENSRNOG00000006304Mdm2rattus_norvegicus
Zebrafish (Danio rerio)ENSDARG00000033443mdm2danio_rerio
Fruit fly (Drosophila)No direct ortholog--
Worm (C. elegans)No direct ortholog--
Yeast (S. cerevisiae)No ortholog--
Entrez Orthologs (Model Organisms)
SpeciesEntrez ID
Mouse17246
Rat314856
Zebrafish30637

Section 6: Clinical Variants & AI Predictions ClinVar Variant Summary Total ClinVar entries: 171

ClassificationCount
Pathogenic0
Likely Pathogenic1
Uncertain Significance (VUS)~85
Likely Benign~55
Benign~10
Conflicting Classifications2
Not Provided~18
Likely Pathogenic/Pathogenic Variant
Variant IDHGVS NotationClassification
694663NM_002392.6(MDM2):c.1492T>C (p.Ter498Gln)Likely pathogenic
TOP 30 Uncertain Significance Variants
ClinVar IDHGVS NotationReview Status
1000905c.583A>G (p.Ile195Val)Single submitter
1019954c.1232A>G (p.Tyr411Cys)Multiple submitters
1025823c.560G>C (p.Arg187Thr)Single submitter
1046432c.350A>G (p.Asn117Ser)Multiple submitters
1058916c.1121A>G (p.Asn374Ser)Multiple submitters
1368535c.1242A>C (p.Gln414His)Single submitter
1371263c.698_700del (p.Gly233del)Single submitter
1378191c.1002T>A (p.Asn334Lys)Single submitter
1384380c.185A>T (p.Tyr62Phe)Single submitter
1386125c.523+5A>GMultiple submitters
1389831c.971A>T (p.His324Leu)Single submitter
1407040c.154G>C (p.Asp52His)Single submitter
1407903c.1039A>G (p.Ile347Val)Single submitter
1416821c.226A>C (p.Lys76Gln)Single submitter
1431908c.365C>T (p.Ser122Leu)Multiple submitters
1437659c.948A>C (p.Glu316Asp)Single submitter
1437694c.1219A>G (p.Ser407Gly)Single submitter
1448253c.1289A>T (p.Glu430Val)Single submitter
1466586c.913T>G (p.Leu305Val)Single submitter
1471228c.886T>G (p.Ser296Ala)Single submitter
1482898c.536A>G (p.Asp179Gly)Single submitter
1501438c.212G>A (p.Arg71Gln)Single submitter
1504296c.818A>C (p.Glu273Ala)Multiple submitters
1507206c.1237A>G (p.Ser413Gly)Single submitter
1930017c.589C>T (p.Leu197Phe)Single submitter
1934140c.1114A>G (p.Ile372Val)Single submitter
1938361c.398G>A (p.Cys133Tyr)Single submitter
2015499c.1030A>G (p.Lys344Glu)Single submitter
2067239c.643A>G (p.Arg215Gly)Single submitter
2123088c.305A>G (p.His102Arg)Single submitter
SpliceAI Predictions Total SpliceAI entries: 2,366 TOP 50 Predicted Splice-Altering Variants
VariantEffectDelta Score
12:68808436:G:Tdonor_gain0.99
12:68808488:GCAGG:Gdonor_loss0.98
12:68808489:CAGG:Cdonor_loss0.98
12:68808490:AG:Adonor_loss0.98
12:68808492:G:Adonor_loss0.98
12:68808436:G:GTdonor_gain0.98
12:68808488:GCAG:Gdonor_gain0.96
12:68808342:G:GGdonor_gain0.94
12:68808373:A:Tdonor_gain0.93
12:68808429:A:Tdonor_gain0.93
12:68808428:G:GTdonor_gain0.91
12:68808341:A:AGdonor_gain0.89
12:68808489:C:Tdonor_gain0.86
12:68808494:A:Cdonor_loss0.84
12:68808476:GGATG:Gdonor_gain0.84
12:68808477:GATG:Gdonor_gain0.81
12:68808477:GATGG:Gdonor_gain0.84
12:68808486:GAGCA:Gdonor_loss0.80
12:68808399:G:GTdonor_gain0.77
12:68808526:C:Adonor_gain0.69
12:68808478:ATG:Adonor_loss0.69
12:68808479:TGG:Tdonor_loss0.69
12:68808480:GG:Gdonor_loss0.69
12:68808481:GT:Gdonor_loss0.69
12:68808482:TGA:Tdonor_loss0.69
AlphaMissense Predictions Total AlphaMissense entries: 3,251 TOP 50 Predicted Pathogenic Missense Variants
VariantProtein ChangeAM ScoreClassification
12:68809215:T:CC2R0.795likely_pathogenic
12:68809217:C:GC2W0.805likely_pathogenic
12:68809229:G:AM6I0.720likely_pathogenic
12:68809229:G:CM6I0.720likely_pathogenic
12:68809229:G:TM6I0.720likely_pathogenic
12:68809215:T:AC2S0.700likely_pathogenic
12:68809216:G:CC2S0.700likely_pathogenic
12:68809216:G:AC2Y0.611likely_pathogenic
AlphaMissense Distribution Summary
ClassificationApproximate Count
Likely Pathogenic~100-200
Ambiguous~300-500
Likely Benign~2,500+

Section 7: Biological Pathways & Gene Ontology Reactome Pathways Total pathway count: 16

Pathway IDNameDisease Pathway
R-HSA-69541Stabilization of p53No
R-HSA-6804756Regulation of TP53 Activity through PhosphorylationNo
R-HSA-6804757Regulation of TP53 DegradationNo
R-HSA-6804760Regulation of TP53 Activity through MethylationNo
R-HSA-198323AKT phosphorylates targets in the cytosolNo
R-HSA-2559580Oxidative Stress Induced SenescenceNo
R-HSA-2559585Oncogene Induced SenescenceNo
R-HSA-3232118SUMOylation of transcription factorsNo
R-HSA-3232142SUMOylation of ubiquitinylation proteinsNo
R-HSA-399719Trafficking of AMPA receptorsNo
R-HSA-5674400Constitutive Signaling by AKT1 E17K in CancerYes
R-HSA-5689880Ub-specific processing proteasesNo
R-HSA-8941858Regulation of RUNX3 expression and activityNo
R-HSA-9725370Signaling by ALK fusions and activated point mutantsYes
R-HSA-9766229Degradation of CDH1No
R-HSA-9768919NPAS4 regulates expression of target genesNo
Gene Ontology Annotations Total GO annotations: 96 Biological Process (58 terms - TOP 20)
GO IDTerm
GO:0000122negative regulation of transcription by RNA polymerase II
GO:0000209protein polyubiquitination
GO:0006511ubiquitin-dependent protein catabolic process
GO:0006915apoptotic process
GO:0008284positive regulation of cell population proliferation
GO:0016567protein ubiquitination
GO:0016925protein sumoylation
GO:0030330DNA damage response, signal transduction by p53 class mediator
GO:0031648protein destabilization
GO:0032436positive regulation of proteasomal ubiquitin-dependent protein catabolic process
GO:0043066negative regulation of apoptotic process
GO:0043161proteasome-mediated ubiquitin-dependent protein catabolic process
GO:0043518negative regulation of DNA damage response by p53 class mediator
GO:0045892negative regulation of DNA-templated transcription
GO:0045931positive regulation of mitotic cell cycle
GO:0046827positive regulation of protein export from nucleus
GO:0051726regulation of cell cycle
GO:0051865protein autoubiquitination
GO:0071456cellular response to hypoxia
GO:1901797negative regulation of signal transduction by p53 class mediator
Molecular Function (18 terms - ALL)
GO IDTerm
GO:0002039p53 binding
GO:0004842ubiquitin-protein transferase activity
GO:00080975S rRNA binding
GO:0008270zinc ion binding
GO:0016874ligase activity
GO:0019789SUMO transferase activity
GO:0019899enzyme binding
GO:0019904protein domain specific binding
GO:0031625ubiquitin protein ligase binding
GO:0033612receptor serine/threonine kinase binding
GO:0042802identical protein binding
GO:0042975peroxisome proliferator activated receptor binding
GO:0043021ribonucleoprotein complex binding
GO:0043130ubiquitin binding
GO:0061630ubiquitin protein ligase activity
GO:0061663NEDD8 ligase activity
GO:0097718disordered domain specific binding
Cellular Component (20 terms - ALL)
GO IDTerm
GO:0005634nucleus
GO:0005654nucleoplasm
GO:0005730nucleolus
GO:0005737cytoplasm
GO:0005829cytosol
GO:0005886plasma membrane
GO:0014069postsynaptic density
GO:0017053transcription repressor complex
GO:0030666endocytic vesicle membrane
GO:0032991protein-containing complex
GO:0034451centriolar satellite
GO:0097225sperm midpiece
GO:0097228sperm principal piece
GO:0097229sperm end piece
GO:0098978glutamatergic synapse

Section 8: Protein Interactions & Molecular Networks STRING Interactions Total STRING interactions: 6,454 TOP 50 Highest-Confidence Interacting Proteins

Interactor UniProtGene SymbolConfidence Score
P04637TP53999
P42771CDKN2A999
Q00987MDM2 (self)999
P25121RELT997
Q9BT92TCHP997
P46777RPL5996
Q93009USP7995
Q09472EP300994
Q9Y6R0NUMBL992
P49757NUMB990
O15151MDM4986
O43524FOXO3983
Q01094E2F1981
P10275AR980
P31749AKT1980
P61254RPL26971
O75832PDE10A965
Q13315ATM955
P10415BCL2953
Q9NRM7UHRF2953
Q9UER7DAXX953
P23396RPS3941
P49407ARRB1935
Q16665HIF1A929
P06400RB1925
Q9BVP2GNL3924
P24385CCND1898
P11174ALPI896
P32121ARRB2890
Q15910EZH2885
P11802CDK4884
P06748NPM1880
Q96DY7SUSD4880
O95155UBE2E3879
P38936CDKN1A (p21)873
O15350TP73868
P55211CASP9864
Q13547HDAC1864
P48729CSNK1A1847
O96017CHEK2838
P60484PTEN838
P42677RPS27821
P35222CTNNB1818
Q96PM5CXXC4815
Q99728BARD1812
P02403RPL4811
P07900HSP90AA1810
P42574CASP3803
P31947SFN800
P24522GAST797
BioGRID Interactions Total BioGRID interactions: 2,701 TOP Experimental Interactions by Evidence Type
InteractorExperimental System
TP53Reconstituted Complex, Two-hybrid, Biochemical Activity, Affinity Capture-Western
MDM2 (self)Affinity Capture-Western, Reconstituted Complex, Co-localization, Biochemical Activity
MDM4Reconstituted Complex, Affinity Capture-Western
UBE2D1Reconstituted Complex
UBE2D2Reconstituted Complex
RCHY1Reconstituted Complex
PMLAffinity Capture-Western
RPL23Affinity Capture-Western
RPL26Affinity Capture-Western
RPS6Affinity Capture-Western
RPS7Affinity Capture-Western
NCLAffinity Capture-Western, Reconstituted Complex
ARIH2Affinity Capture-Western
AATFAffinity Capture-Western
WWOXAffinity Capture-Western
HIF1AAffinity Capture-Western
RELAReconstituted Complex, Affinity Capture-Western
FOXO1Biochemical Activity
ARAffinity Capture-Western, Reconstituted Complex
ARRB1Two-hybrid
ARRB2Two-hybrid
SMARCA2Reconstituted Complex
RAD54BAffinity Capture-Western
UBE2IProtein-peptide
UBE2MReconstituted Complex
Protein Similarity ESM2 Structural/Embedding Similarity Total similar proteins: 33
UniProt IDTop SimilarityAvg SimilarityProtein
O151510.99870.9816MDM4 (MDMX)
O356180.99950.9817Mouse Mdm2
P569500.99970.9857Chimpanzee MDM2
P569510.99970.9854Gorilla MDM2
Q5FWP40.99970.9827Orangutan MDM2
Q7YRZ80.99970.9857Macaque MDM2
Q6P2560.99970.9823Bonobo MDM2
Q5XIN10.99950.9829Rhesus MDM2
Q80XJ20.99930.9879Mouse Mdm2
Q80Z370.99920.9817Mouse Mdm4
Q9NS560.99920.9815MDM4 isoform
P238040.99890.9861Dog MDM2
DIAMOND Sequence Similarity (TOP 15)
UniProt IDTop Identity %BitscoreProtein
Q5XIN194.9%926Rhesus MDM2
O3561894.9%923Mouse Mdm2
P5695095.1%908Chimpanzee MDM2
P5695194.5%904Gorilla MDM2
Q7YRZ895.1%905Macaque MDM2
Q0098794.5%900Human MDM2 (self)
O1515190.0%872Human MDM4
Q2HJ2190.0%872Bovine MDM2
Q6052482.6%734Mouse Mdm4
P2380478.2%715Dog MDM2

Section 9: Transcription Factor Regulatory Data Upstream Regulators (TFs that regulate MDM2) Total CollecTRI entries: 80 TOP 50 Transcriptional Regulators of MDM2

TF GeneRegulation TypeConfidence
TP53ActivationHigh
SP1ActivationHigh
JUNActivationHigh
NFKBActivationHigh
ETS2ActivationHigh
ELF4ActivationHigh
NFATC2ActivationHigh
AHRActivationHigh
CREB1UnknownHigh
ESR1UnknownHigh
SMAD3UnknownHigh
TP73UnknownHigh
MYCNUnknownHigh
HIF1AUnknownHigh
NFE2L2UnknownHigh
NKX3-1UnknownHigh
VDRUnknownHigh
NR2F2UnknownHigh
HRUnknownHigh
PAX1UnknownHigh
IRF8UnknownHigh
E2F1RepressionHigh
ETS1RepressionHigh
STAT1RepressionHigh
TFAP4RepressionHigh
FEZF2RepressionHigh
NR4A1RepressionHigh
ARUnknownHigh
BCL11BUnknownHigh
FOSActivationLow
MYCActivationLow
E2F2Repression-
WT1Repression-
CDKN2AIPRepression-
ELLRepression-
FUSRepression-
NACC2Repression-
NKX6-3Repression-
MLLT10Repression-
MLLT3Repression-
TAF1RepressionLow
ZKSCAN4Repression-
BCL3Activation-
BRCA1Activation-
FOSL2Activation-
JUNDActivation-
NFKB1Activation-
NR2F1Activation-
SKIActivation-
SRSF2Activation-
MDM2 as Regulator (Downstream Targets) MDM2 regulates:
Target GeneRegulationEvidence
DNMT3AActivationCollecTRI
PIK3R1UnknownCollecTRI
SIGNOR Regulatory Network (MDM2 Substrates) MDM2 ubiquitinates/regulates 27+ proteins:
TargetEffectMechanism
TP53down-regulates (destabilization)ubiquitination
MDM4down-regulatesubiquitination
HIF1Adown-regulates (destabilization)ubiquitination
RB1down-regulates (destabilization)ubiquitination
CDKN1Adown-regulates (destabilization/repression)binding
TP73down-regulates activitybinding
RUNX3down-regulates (destabilization)ubiquitination
IGF1Rdown-regulates (destabilization)ubiquitination
DYRK2down-regulates (destabilization)ubiquitination
KAT5down-regulates (destabilization)polyubiquitination
FOXO4down-regulates activityubiquitination
PPARGdown-regulates (destabilization)ubiquitination
APEX1down-regulates (destabilization)ubiquitination
IRF1down-regulatesubiquitination
SIRT6down-regulatesubiquitination
PER2down-regulates (destabilization)polyubiquitination
NOTCH1up-regulatesubiquitination
NOTCH4down-regulatesubiquitination
SIGNOR Regulatory Network (MDM2 Regulators) MDM2 is regulated by 30+ kinases/proteins:
RegulatorEffect on MDM2Mechanism
AKT1/AKT2up-regulates (stabilization/activity)phosphorylation
ATMdown-regulates activityphosphorylation
ATRdown-regulates activityphosphorylation
ABL1down-regulatesphosphorylation
BTKdown-regulates activityphosphorylation
CSNK1Ddown-regulatesphosphorylation
PIM1up-regulates (stabilization)phosphorylation
PLK1up-regulatesphosphorylation
PAK6up-regulates activityphosphorylation
MAPKAPK2up-regulates (stabilization)phosphorylation
DAPK3up-regulates (stabilization)phosphorylation
USP7up-regulatesdeubiquitination
PPM1Dup-regulates / down-regulatesdephosphorylation
PPP1CA/CB/CCup-regulates (stabilization)dephosphorylation
PPP2CA/CBup-regulates activitydephosphorylation
MDM4up-regulates (stabilization)binding
CDKN2Adown-regulates activityrelocalization
TRIM13down-regulates (destabilization)polyubiquitination
TRIM28up-regulates activitybinding
NUMBdown-regulatesbinding
DAXXup-regulatesbinding
ARRB2up-regulates (stabilization)binding
FBXO22down-regulates (destabilization)ubiquitination
FBXO31down-regulates (destabilization)binding
PYHIN1down-regulates (destabilization)binding

Section 10: Drug & Pharmacology Data ChEMBL Target Information Primary Target ID: CHEMBL5023 (Single Protein) Protein-Protein Interaction Target: CHEMBL1907611 (p53-MDM2) ChEMBL Target Types for MDM2

Target IDTarget TypeDescription
CHEMBL5023SINGLE PROTEINE3 ubiquitin-protein ligase Mdm2
CHEMBL1907611PROTEIN-PROTEIN INTERACTIONTumour suppressor p53/oncoprotein Mdm2
CHEMBL3883306PROTEIN-PROTEIN INTERACTIONMDM2/MDMX-p53
CHEMBL4106123PROTEIN-PROTEIN INTERACTIONMDM2-MDMX
CHEMBL4523702PROTEIN-PROTEIN INTERACTIONProtein cereblon/E3 ubiquitin-protein ligase Mdm2
CHEMBL4523718PROTEIN-PROTEIN INTERACTIONE3 ubiquitin-protein ligase Mdm2/CDK6
CHEMBL4523719PROTEIN-PROTEIN INTERACTIONBRD4/E3 ubiquitin-protein ligase Mdm2
CHEMBL4523720PROTEIN-PROTEIN INTERACTIONGSPT1/E3 ubiquitin-protein ligase Mdm2
CHEMBL5291692PROTEIN-PROTEIN INTERACTIONvon Hippel-Lindau/E3 ubiquitin-protein ligase Mdm2
CHEMBL5465251PROTEIN-PROTEIN INTERACTIONMDM2-HDAC3
CHEMBL5465382PROTEIN-PROTEIN INTERACTIONMDM2-HDAC1
CHEMBL5465383PROTEIN-PROTEIN INTERACTIONMDM2-HDAC2
CHEMBL3038493PROTEIN COMPLEXCasein kinase I/MDM2
TOP MDM2 Inhibitors by Development Phase
ChEMBL IDDrug NameTypePhaseMechanism
CHEMBL572NITROFURANTOINSmall molecule4 (Approved)MDM2 inhibitor
CHEMBL2402737IDASANUTLINSmall molecule3p53-MDM2 inhibitor
CHEMBL3125702NAVTEMADLIN (AMG-232)Small molecule3p53-MDM2 inhibitor
CHEMBL4292264MILADEMETAN (DS-3032)Small molecule3p53-MDM2 inhibitor
CHEMBL120563THIRAMSmall molecule2-
Detailed Drug Information IDASANUTLIN (RG7388, RO5503781)
  • ChEMBL ID: CHEMBL2402737
  • Highest Development Phase: 3
  • Type: Small molecule
  • Clinical Trials: 17 Indications Studied:
IndicationPhase
Acute Myeloid LeukemiaPhase 3
NeoplasmPhase 2
Polycythemia VeraPhase 2
LymphomaPhase 1
GliomaPhase 1
Multiple MyelomaPhase 1
Breast CancerPhase 1
Colorectal CancerPhase 1
NAVTEMADLIN (AMG-232, KRT-232)
  • ChEMBL ID: CHEMBL3125702
  • Highest Development Phase: 3
  • Type: Small molecule
  • Clinical Trials: 20 Indications Studied:
IndicationPhase
LiposarcomaPhase 3
Polycythemia VeraPhase 2
Primary MyelofibrosisPhase 2
Small Cell Lung CancerPhase 2
TP53 Wild-type Solid TumorsPhase 2
Acute Myeloid LeukemiaPhase 1
GlioblastomaPhase 1
MelanomaPhase 1
Myelodysplastic SyndromesPhase 1
MILADEMETAN (DS-3032, RAIN-32)
  • ChEMBL ID: CHEMBL4292264
  • Highest Development Phase: 3
  • Type: Small molecule
  • Clinical Trials: 10 Indications Studied:
IndicationPhase
LiposarcomaPhase 3
SarcomaPhase 2
MelanomaPhase 2
Ovarian CancerPhase 2
Pancreatic CancerPhase 2
Acute Myeloid LeukemiaPhase 1
Solid TumorsPhase 1
Clinical Trials for IDASANUTLIN (TOP 15)
Trial IDTitlePhaseStatus
NCT02545283Idasanutlin + Cytarabine vs Placebo in R/R AMLPhase 3Terminated
NCT02624986Idasanutlin + Obinutuzumab in R/R FL and DLBCLPhase 1/2Terminated
NCT02633059Idasanutlin + Ixazomib + Dexamethasone in R/R MMPhase 1/2Completed
NCT03135262Obinutuzumab + Idasanutlin + Venetoclax in R/R FLPhase 1/2Terminated
NCT03158389NCT Neuro Master Match - N²M² (NOA-20)Phase 1/2Completed
NCT03287245Idasanutlin Monotherapy in Polycythemia VeraPhase 2Terminated
NCT03555149Immunotherapy Combinations in Metastatic CRCPhase 1/2Terminated
NCT03566485Atezolizumab + Cobimetinib/Idasanutlin in ER+ BreastPhase 1/2Terminated
NCT03850535Idasanutlin + Cytarabine + Daunorubicin in New AMLPhase 1/2Terminated
NCT04029688Idasanutlin + Chemo/Venetoclax in Pediatric LeukemiasPhase 1/2Terminated
NCT01462175First-In-Human Study of RO5503781Phase 1Completed
NCT01901172DDI and Bioavailability Study of RO5503781Phase 1Completed
NCT02407080Single Agent RG7388 in PV and ETPhase 1Completed
NCT02670044Venetoclax + Cobimetinib/Idasanutlin in R/R AMLPhase 1Completed
NCT02828930ADME Study of [14C]-IdasanutlinPhase 1Completed
Pharmacogenomics (PharmGKB)
  • PharmGKB Gene ID: PA30718
  • VIP Gene: Yes
  • CPIC Guideline: No Related Drug Classes:
Drug/ClassClinical AnnotationsVariant Annotations
Platinum compounds3001,138
Nutlin-300

Section 11: Expression Profiles Tissue Expression (Bgee)

AttributeValue
GeneENSG00000135679 / MDM2
SpeciesHomo sapiens
Expression BreadthUbiquitous
Total Present Calls274
Max Expression Score98.31
Expression Pattern: MDM2 is ubiquitously expressed across virtually all human tissues, with high expression scores indicating robust expression in most tissue types. Single-Cell Expression Data (Expression Atlas)
Experiment IDDescriptionSpeciesCell Count
E-CURD-53Gene expression profiling of SARS-CoV-1/2 infected human cell linesHomo sapiens187,349
E-MTAB-7051Single-cell RNA-seq of dermal fibroblasts (IFNB stimulation)Homo sapiens681
E-MTAB-7303scRNA-seq of iPSC-dopamine neurons - Parkinson's diseaseHomo sapiens123

Section 12: Disease Associations Mendelian/Monogenic Disease Links GenCC Disease-Gene Associations

DiseaseDisease IDClassificationInheritanceSubmitter
Lessel-Kubisch syndromeOMIM:618681LimitedUnknownLabcorp Genetics
Li-Fraumeni syndromeOrphanet:524SupportiveAutosomal dominantOrphanet
Orphanet Rare Disease Associations
Orphanet IDDisease NameTypeGene CountPhenotypes
524Li-Fraumeni syndromeDisease435
99970Dedifferentiated liposarcomaHistopathological subtype30
99971Well-differentiated liposarcomaHistopathological subtype33
HPO Phenotype Associations Total HPO associations: 49 Cancer-Related Phenotypes (TOP 30)
HPO IDPhenotype
HP:0002664Neoplasm
HP:0002665Lymphoma
HP:0002669Osteosarcoma
HP:0002859Rhabdomyosarcoma
HP:0002861Melanoma
HP:0002863Myelodysplasia
HP:0002885Medulloblastoma
HP:0002888Ependymoma
HP:0002890Thyroid carcinoma
HP:0002894Neoplasm of the pancreas
HP:0003002Breast carcinoma
HP:0003003Colon cancer
HP:0004808Acute myeloid leukemia
HP:0006721Acute lymphoblastic leukemia
HP:0006744Adrenocortical carcinoma
HP:0007378Neoplasm of the gastrointestinal tract
HP:0009592Astrocytoma
HP:0009726Renal neoplasm
HP:0010788Testicular neoplasm
HP:0012125Prostate cancer
HP:0012126Stomach cancer
HP:0012174Glioblastoma multiforme
HP:0012189Hodgkin lymphoma
HP:0012288Neoplasm of head and neck
HP:0012539Non-Hodgkin lymphoma
HP:0030070Central primitive neuroectodermal tumor
HP:0030392Choroid plexus carcinoma
HP:0100006Neoplasm of the central nervous system
HP:0100526Neoplasm of the lung
HP:0100615Ovarian neoplasm
Other Phenotypes
HPO IDPhenotype
HP:0000007Autosomal recessive inheritance
HP:0000083Renal insufficiency
HP:0000089Renal hypoplasia
HP:0000135Hypogonadism
HP:0000160Narrow mouth
HP:0000446Narrow nasal bridge
HP:0000822Hypertension
HP:0001482Subcutaneous nodule
HP:0001620Abnormally high-pitched voice
HP:0001909Leukemia
HP:0002216Premature graying of hair
HP:0002225Sparse pubic hair
HP:0002579Gastrointestinal dysmotility
HP:0004322Short stature
HP:0100743Neoplasm of the rectum
HP:0100768Choriocarcinoma
HP:0200063Colorectal polyposis
HP:0012211Abnormal renal physiology
GWAS Associations Total GWAS associations: 2
Study IDTraitMapped GeneChrP-value
GCST90002403_354Red blood cell countMDM2124.0 × 10⁻¹¹
GCST002515_1Pneumoconiosis in silica exposureCPM - CPSF6122.0 × 10⁻⁸

SUMMARY STATISTICS

CategoryCount
Ensembl Transcripts40
RefSeq mRNA Transcripts (human)10
CCDS IDs3
Exons (canonical transcript)11
UniProt Entries1 (Q00987)
InterPro Domains/Families9
Pfam Domains3
PDB Structures147+
Model Organism Orthologs3
ClinVar Variants171
SpliceAI Predictions2,366
AlphaMissense Predictions3,251
Gene Ontology Terms96
Reactome Pathways16
STRING Interactions6,454
BioGRID Interactions2,701
SIGNOR Regulatory Entries127
CollecTRI TF Interactions80
ChEMBL Activity Records8,349+
Clinical Trials (p53-MDM2)47+
HPO Phenotypes49
GWAS Associations2

╔══════════════════════════════════════════════════════════════════════════════╗ ║ END OF MDM2 REFERENCE ║ ║ ║ ║ Data Sources: HGNC, Ensembl, NCBI, UniProt, PDB, AlphaFold, ClinVar, ║ ║ SpliceAI, AlphaMissense, Reactome, Gene Ontology, STRING, BioGRID, ║ ║ SIGNOR, CollecTRI, ChEMBL, PharmGKB, Bgee, Orphanet, HPO, GWAS Catalog ║ ║ ║ ║ Generated: 2026-03-29 ║ ╚══════════════════════════════════════════════════════════════════════════════╝